Product A

•Ophthalmic Unit Dose

•Approval 2022 •$38M, increasing volume

•1 generic

Product B

•Otic Unit Dose

•$5.5M, sales to increase due to expansion

•CGT, submission batches will be manufactured in Q1,2022

Contact us below to learn more!